Embecta (EMBC) Non-Current Assets (2021 - 2026)
Embecta's (EMBC) quarterly Non-Current Assets came in at $421.2 million in Q1 2026, down 11.66% year-on-year from $476.8 million in Q1 2025, and down 5.03% quarter-over-quarter from $443.5 million in Q4 2025.
Embecta (EMBC) Non-Current Assets (2021 - 2026) Analysis & Trends
Embecta has disclosed Non-Current Assets across 6 years of filings, most recently posting $421.2 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $421.2 million, down 11.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 8.62% YoY), and the FY2025 annual result was $459.5 million, down 12.36% from the prior year.
- Non-Current Assets came in at $421.2 million for Q1 2026 at Embecta, down from $443.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $524.3 million in Q3 2024 to a low of $407.0 million in Q1 2022.
- The 5-year median for Non-Current Assets is $465.3 million (2023), against an average of $463.2 million.
- Across the five-year window, Non-Current Assets retreated 15.01% in 2022 and rose 14.5% in 2023, its largest moves.
- Embecta's Non-Current Assets stood at $435.2 million in 2022, then increased by 14.5% to $498.3 million in 2023, then dropped by 3.21% to $482.3 million in 2024, then fell by 8.04% to $443.5 million in 2025, then dropped by 5.03% to $421.2 million in 2026.
- The last three Non-Current Assets figures came in at $421.2 million (Q1 2026), $443.5 million (Q4 2025), and $459.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 11.30 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 42.82 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 27.83 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 4.72 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 2.28 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 10.51 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.66 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.00 Bn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 421.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421.20 Mn |
| Dec 31, 2025 | 443.50 Mn |
| Sep 30, 2025 | 459.50 Mn |
| Jun 30, 2025 | 475.80 Mn |
| Mar 31, 2025 | 476.80 Mn |
| Dec 31, 2024 | 482.30 Mn |
| Sep 30, 2024 | 524.30 Mn |
| Jun 30, 2024 | 486.40 Mn |
| Mar 31, 2024 | 489.60 Mn |
| Dec 31, 2023 | 498.30 Mn |
| Sep 30, 2023 | 465.30 Mn |
| Jun 30, 2023 | 464.60 Mn |
| Mar 31, 2023 | 453.70 Mn |
| Dec 31, 2022 | 435.20 Mn |
| Sep 30, 2022 | 421.70 Mn |
| Jun 30, 2022 | 469.20 Mn |
| Mar 31, 2022 | 407.00 Mn |
| Dec 31, 2021 | 481.60 Mn |
| Sep 30, 2021 | 496.20 Mn |